Sukumar Nagendran - 16 Jun 2021 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by Erin P. Brennan as attorney-in-fact for Sukumar Nagendran
Issuer symbol
SLDB
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 16:00:17 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 16 Jun 2021 Common Stock 30,000 $3.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 16, 2021 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Remarks:

Exhibit Index: 24.1 Power of Attorney